Glulisine + Lantus in Type I Patients
NCT00546702
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
142
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG:
Insuline Glulisine
Sponsor
Sanofi